Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study
- PMID: 19187547
- PMCID: PMC2646730
- DOI: 10.1186/1757-2215-2-3
Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study
Abstract
Background: Polycystic ovary syndrome (PCOS) is an endocrine disease closely related to several risk factors for cardiovascular disease. An abnormal heart rate recovery (HRR), an easily-obtained measure derived from exercise stress test and closely related to an increased risk for cardiovascular mortality, has been recently described in PCOS women. A subclinical increase of the inflammation markers has been also observed in the PCOS. This study was designed to study the relationships between HRR and inflammatory markers in PCOS women.
Methods: Two-hundred forty-three young PCOS patients without known risk factors for cardiovascular risk were enrolled. All patients underwent hormonal and metabolic profile, white blood cells (WBCs) count and C-reactive protein (CRP). HRR was calculated as the difference between heart rate at peak exercise and heart rate at first minute of the cool-down period. Abnormal HRR was defined as </=18 beats/min for standard exercise testing.
Results: Eighty-nine out of 243 patients presented abnormal HRR. Serum CRP (1.8 +/- 0.7 vs. 1.1 +/- 0.4 mg/dl, p < 0.001) and WBCs (7.3 +/- 1.8 vs. 6.6 +/- 1.5 109 cells/l, p < 0.001) concentrations were significantly higher in PCOS patients with abnormal versus normal HRR. HRR was significantly associated with both CRP (r = -0.33, p < 0.001) and WBCs (r = -0.29, p < 0.001), although in a stepwise multiple regression HRR resulted independently associated with CRP (beta = -0.151, p = 0.001) alone. In a logistic multivariate model, the group within the highest quartile of CRP (odds ratio 1.59, 95% CI 1.07-2.33) was more likely to have abnormal HRR than those within the lowest quartile.
Conclusion: Abnormal HRR and inflammatory markers are closely associated in PCOS women acting probably in concert to increase the cardiovascular risk profile of these patients.
Figures
Similar articles
-
Relation of heart rate recovery after exercise to C-reactive protein and white blood cell count.Am J Cardiol. 2007 Mar 1;99(5):707-10. doi: 10.1016/j.amjcard.2006.09.121. Epub 2007 Jan 10. Am J Cardiol. 2007. PMID: 17317377
-
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).Clin Endocrinol (Oxf). 2008 Nov;69(5):792-8. doi: 10.1111/j.1365-2265.2008.03305.x. Epub 2008 May 23. Clin Endocrinol (Oxf). 2008. PMID: 18505468 Clinical Trial.
-
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome.Clin Endocrinol (Oxf). 2008 Jan;68(1):88-93. doi: 10.1111/j.1365-2265.2007.03004.x. Epub 2007 Sep 4. Clin Endocrinol (Oxf). 2008. PMID: 17803701 Clinical Trial.
-
Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome.Int J Cardiol. 2008 Oct 30;130(1):49-55. doi: 10.1016/j.ijcard.2007.08.037. Epub 2007 Dec 4. Int J Cardiol. 2008. PMID: 18055040
-
Chronic Low Grade Inflammation in Pathogenesis of PCOS.Int J Mol Sci. 2021 Apr 6;22(7):3789. doi: 10.3390/ijms22073789. Int J Mol Sci. 2021. PMID: 33917519 Free PMC article. Review.
Cited by
-
Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis.Syst Rev. 2024 Jul 24;13(1):194. doi: 10.1186/s13643-024-02617-x. Syst Rev. 2024. PMID: 39049099 Free PMC article. Review.
-
Is the Effect of the COVID-19 Vaccine on Heart Rate Variability Permanent?Medicina (Kaunas). 2023 Apr 28;59(5):852. doi: 10.3390/medicina59050852. Medicina (Kaunas). 2023. PMID: 37241084 Free PMC article.
-
Heart rate variability in normal-weight patients with polycystic ovary syndrome.Anatol J Cardiol. 2017 May;17(5):404-409. doi: 10.14744/AnatolJCardiol.2017.7473. Epub 2017 Mar 9. Anatol J Cardiol. 2017. PMID: 28315565 Free PMC article.
-
The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes.J Endocrinol Invest. 2016 Aug;39(8):899-907. doi: 10.1007/s40618-016-0446-4. Epub 2016 Mar 15. J Endocrinol Invest. 2016. PMID: 26980590
-
Brachial-to-ankle pulse wave velocity as an independent prognostic factor for ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.J Ovarian Res. 2014 Jul 10;7:74. doi: 10.1186/1757-2215-7-74. eCollection 2014. J Ovarian Res. 2014. PMID: 25024746 Free PMC article.
References
-
- Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C. Cardiovascular risk in women with polycystic ovary syndrome. J Cardiovasc Med. 2008;9:987–992. - PubMed
-
- Orio F, Jr, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T, Labella D, Zullo F, Lombardi G, Colao A. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:4588–4593. doi: 10.1210/jc.2003-031867. - DOI - PubMed
-
- Orio F, Jr, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanova L, Nardo LG, Labella D, Savastano S, Russo T, Zullo F, Colao A, Lombardi G. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:2–5. doi: 10.1210/jc.2004-0628. - DOI - PubMed
-
- Cascella T, Palomba S, Tauchmanovà L, Manguso F, Di Biase S, Labella D, Giallauria F, Vigorito C, Colao A, Lombardi G, Orio F. Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2006;91:4395–4400. doi: 10.1210/jc.2006-0399. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous